BTL,a leader in medical innovation,is proud to announce a major milestone: the successful treatment of the first patients suffering from atrial fibrillation (AF) in a groundbreaking study using a next
LISHUI,China,Dec. 4,2024-- CN Energy Group. Inc. (NASDAQ:CNEY) ("CNEY" or the "Company") today announced that on November 26,2024,the Company received a written notice from the Lis
Patient advocates call for more support for Australian workers living with a chronic condition/s following therelease of anew insights report
HONG KONG,Dec. 4,2024--Dunxin Financial Holdings Limited ("Dunxin" or the "Company") (OTC Pink: DXFFY),a company engaged in real estate operation management and investment and a di
SINGAPORE,Dec. 4,2024-- McCann Worldgroup has launched its latest insights study,the Truth about Ascending Asia,at an event held at Singapore\'s Asian Civilisations Museum. Over 70 clients,partners an
In a Pitch Cycle That Saw 50% Churn Rate,OMG Is #1 for Retention,Holding on to 85% of Its Billings in Play
After years of commitment to animal health in the Asian market providing high-quality biotechnological solutions,this significant milestone further strengthens the company\'s long-term expansion stra
First Implants of Innovative Device Completed in the United States and Australia MINNEAPOLIS,Dec. 3,2024--ShiraTronics,a clinical-stage innovator in neuromodulation technology,today announced the ini
SHANGHAI,Dec. 4,2024-- 26th China Clean Expo (CCE),organized by IM Sinoexpo and supported by ISSA – The worldwide cleaning industry association,will take place at Shanghai New International Expo Cent
VVN461,a non-steroidal dual JAK1/TYK2 immunomodulator,achieves primary endpoint,demonstrating statistical and clinical efficacy compared to vehicle in treatingpost-operative inflammation following cat
